Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Tolimidone

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biodexa's Phase 2a Study Of Tolimidone For T1D Approved In Canada
    Biodexa's Phase 2a Study Of Tolimidone For T1D Approved In Canada

    16 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/16/2913782/0/en/Biodexa-Announces-Phase-2a-Study-of-Tolimidone-in-Type-1-Diabetes-Approved-by-Health-Canada.html

    GLOBENEWSWIRE
    16 Jul 2024
    Share Share
    Biodexa Enters Into Agreements to Acquire Worldwide License to Tolimidone
    Biodexa Enters Into Agreements to Acquire Worldwide License to Tolimidone

    27 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/27/2786218/0/en/Biodexa-Enters-Into-Agreements-to-Acquire-Exclusive-Worldwide-License-to-Tolimidone-a-Phase-II-Ready-Asset-for-Type-1-Diabetes.html

    GLOBENEWSWIRE
    27 Nov 2023
    Share Share
    Adhera Therapeutics Expands Relationship with Melior Pharmaceuticals I,Adds NASH
    Adhera Therapeutics Expands Relationship with Melior Pharmaceuticals I,Adds NASH

    20 Oct 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/10/20/2317559/0/en/Adhera-Therapeutics-Expands-Relationship-with-Melior-Pharmaceuticals-I-Adds-NASH-and-Pulmonary-Inflammation-to-Portfolio-of-Target-Indications.html

    GLOBENEWSWIRE
    20 Oct 2021
    Share Share
    PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC
    PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC

    09 Mar 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210309005100/en

    BUSINESSWIRE
    09 Mar 2021
    Share Share
    Melior Receives IND Clearance from US FDA for COVID-19 Therapeutic
    Melior Receives IND Clearance from US FDA for COVID-19 Therapeutic

    09 Mar 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210309005144/en

    BUSINESSWIRE
    09 Mar 2021
    Share Share
    Melior Pharmaceuticals Awarded Grant for Advancing Pulmonary Therapeutic
    Melior Pharmaceuticals Awarded Grant for Advancing Pulmonary Therapeutic

    15 Sep 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/melior-pharmaceuticals-awarded-grant-for-advancing-pulmonary-therapeutic-in-covid-19-phase-2-clinical-trial/

    BIOSPACE
    15 Sep 2020
    Share Share